Buprenorphine in urine screening

Beckman Coulter has expanded its drugs of abuse test menu to include a Buprenorphine Enzyme Immunoassay. The test provides fast screening for the qualitative and semi-quantitative determination of norbuprenorphine (buprenorphine metabolite) in human urine.

Reagents and calibrators for the assay are liquid and ready to use, eliminating the need to mix, hydrate or pre-dilute reagents before testing. The assay’s cut-off value is 10 ng/mL for norbuprenorphine and it delivers analytical sensitivity of 3 ng/mL for buprenorphine and norbuprenorphine (the active, dealkylated metabolite of buprenorphine). It cross-reacts at 94% with buprenorphine.

Drugs of Abuse Test (DAT) assays, available through Beckman Coulter, are formulated to deliver speed, accuracy, ease of use and economy. When used in conjunction with Synchron, UniCel Clinical Chemistry Systems and i class Integrated Systems, these assays provide timely, reliable and efficient DAT results.